Create a narrative

Alvotech Community

NasdaqGM:ALVO Community

1 Narratives written by author
0 Comments on narratives written by author
8 Fair Values set on narratives written by author

Create a narrative

AN

AnalystConsensusTarget

Consensus Narrative from 4 Analysts

Biosimilar Pipeline And R&D Capability Will Open New Markets

Key Takeaways Upcoming biosimilar launches and strategic manufacturing expansions might drive substantial revenue and margin growth, leveraging lost biologic patents. Strategic R&D expansions, including acquisitions, could enhance pipeline strength, while a Stockholm Exchange listing may boost investor interest and liquidity.

US$18.00

FV

55.9% undervalued

37.91%

Revenue growth p.a.

0

0

1

3 days ago